Triple Antibiotic Plus Pain Relief
- Product NDC
- 42507-679
- 11-digit product format
- 425070679
- Labeler code
- 42507
- Product ID
- 42507-679_a0f2663d-acb6-4828-93b4-74f3423a13ae
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Bacitracin, Neomycin, Polymyxin B, Pramoxine HCl
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Labeler
- HyVee Inc
- Application
- M004
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2015-09-27
- Substance
- BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE
- Active strength
- 500; 3.5; 10000; 10 [USP'U]/g; mg/g; [USP'U]/g; mg/g
- Pharmacologic classes
- Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 42507-679-64 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 42507-679-64 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 42507-679-64 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 42507-679-64 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 42507-679-64 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 42507-679-64 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 42507-679-64 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 42507-679-64 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 42507-679-64 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 42507-679-64 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 42507-679-64 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 42507-679-64 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Triple Antibiotic Plus Pain Relief
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BACITRACIN ZINC | 500 [USP'U]/g |
| NEOMYCIN SULFATE | 3.5 mg/g |
| POLYMYXIN B SULFATE | 10000 [USP'U]/g |
| PRAMOXINE HYDROCHLORIDE | 10 mg/g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 89Y4M234ES | Internal UNII lookup |
| 057Y626693 | Internal UNII lookup |
| 19371312D4 | Internal UNII lookup |
| 88AYB867L5 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1359350 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 69a4b642-b7ec-43cc-aa57-6858da0b3d63 | Available on FDA.report |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GASCO ANTIBACTERIAL | BENZALKONIUM CHLORIDE | GASCO INDUSTRIAL CORP | 411ffefe-16e5-a2e0-e063-6394a90a0cd4 | 2025-10-14 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE. | TRIFECTA PHARMACEUTICALS USA LLC | 4124e9e2-397f-8921-e063-6394a90a5ffe | 2025-10-14 | Warnings | M004 |
| Antibiotic | NEOMYCIN SULFATE | Total Resources International | 0725364b-b243-4891-af2f-a6049366d038 | 2025-10-10 | Warnings | M004 |
| MediChoice Bacitracin | BACITRACIN | O&M HALYARD, INC. | 78079b94-c6fc-4529-aaad-8186924ecba5 | 2025-10-09 | Warnings | M004 |
| MediChoice Triple Antibiotic | BACITRACIN | O&M HALYARD, INC. | 8369f399-6f64-4441-be72-1f16c7306c0a | 2025-10-09 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Medline Industries, LP | 301ebb9a-033b-4f04-99ff-571e921924ca | 2025-10-09 | Warnings | M004 |
| First Aid Antibiotic | BACITRACIN ZINC | Medline Industries, LP | f8282204-f9b9-486f-b18b-dc5ba85cce10 | 2025-10-09 | Warnings | M004 |
| TheraCare Triple Antibiotic Pain Relief | BACITRACIN,NEOMYCIN,POLYMXIN, PRAMOXINE | Veridian Healthcare | faf73908-324f-27f5-e053-6394a90aa06e | 2025-10-02 | Warnings | M004 |
| Viaderma Care First Aid | BACITRACIN ZINC | ViaDerma Distribution, Inc. | dabb7ce8-3284-4dfc-bc6e-38a691be43c1 | 2025-10-02 | Warnings | M004 |
| Double Antibiotic | BACITRACIN ZINC POLYMYXIN B SULFATE | Encube Ethicals, Inc. | 8f00b059-6729-4fae-8e8c-e14fe8838c59 | 2025-09-30 | Warnings | M004 |
| Xpect Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Cintas Corporation | 39355db3-24d7-485f-9ce0-f0e466e96593 | 2025-09-26 | Warnings | M004 |
| TRIPLE ANTIBIOTIC | BACITRACIN ZINC NEOMYCIN SULFATE POLYMYXIN B SULFATE PRAMOXINE HCL | Encube Ethicals, Inc. | dfea6b2e-cd76-439d-a3da-64e2d8717163 | 2025-09-25 | Warnings | M004 |
| TRIPLE ANTIBIOTIC | BACITRACIN ZINC NEOMYCIN SULFATE POLYMYXIN B SULFATE | Encube Ethicals, Inc. | 2e985ad0-aa50-4c6b-b0af-1d61489a9fda | 2025-09-25 | Warnings | M004 |
| Medi-First Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Unifirst First Aid Corporation | f2f0a1da-3e33-3c1a-e053-2a95a90a12b1 | 2025-09-09 | Warnings | M004 |
| Ecolab Triple Antibiotic | BACITRACIN, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Ecolabs Food Safety Specialties, Inc. | 4aef8f98-db76-07f2-e054-00144ff8d46c | 2025-09-09 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Unifirst First Aid Corporation | d265f094-e654-4c68-9215-b5d061af885d | 2025-09-08 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Unifirst First Aid Corporation | d7c1a10e-c38d-4ae8-9a27-c07c2208ca84 | 2025-09-08 | Warnings | M004 |
| Thompson Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Thompson | f883c4cb-c32c-76e3-e053-6294a90aa4fc | 2025-09-08 | Warnings | M004 |
| Thompson Triple Antibiotic | BACITRACIN ZINC, POLYMYXIN B SULFATE, NEOMYCIN SULFATE | Thompson | de9489de-e677-2bd3-e053-2a95a90acfb4 | 2025-09-08 | Warnings | M004 |
| BACITRACIN ZINC | FIRST AID ANTIBIOTIC | Encube Ethicals, Inc. | 613cbed4-9790-4e6b-a61b-b7b7a8ee59c9 | 2025-09-04 | Warnings | M004 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 42507-679-64 | 42507067964 | 1 TUBE in 1 CARTON (42507-679-64) / 28 g in 1 TUBE (42507-679-28) | 1 tube | 2015-09-27 | No | No | Current |